Article Details
Retrieved on: 2019-03-13 00:51:56
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. raised its position in shares of Evelo Biosciences Inc (NASDAQ:EVLO) by 258.0% in the third quarter, according to the company ...</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here